Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-09-21

Clinical Trial Update: Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic Dermatitis

View source ↗

Summary

A clinical trial update exploring how filaggrin (FLG) gene mutation influences treatment outcomes in atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Atopic Dermatitis | Status: UNKNOWN